Mr. Stephen Groarke:

I think this was in the Central Bank's testimony to the committee. Its position is that it is for the bank to decide. It is not for the Central Bank to approve or sign off on any particular treatment. However, if it believes it is appropriate, it might object. At this point we have provided it with all the information and we have had no feedback to the contrary.